1.0Jordan News Gazettehttps://jordannewsgazette.comjadminhttps://jordannewsgazette.com/author/jadmin/rich600338<blockquote class="wp-embedded-content" data-secret="gVVUvKVdQl"><a href="https://jordannewsgazette.com/bcli-final-deadline-tomorrow-rosen-a-top-ranked-law-firm-encourages-brainstorm-cell-therapeutics-inc-investors-with-losses-in-excess-of-500k-to-secure-counsel-before-important-january-2-deadline/">BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://jordannewsgazette.com/bcli-final-deadline-tomorrow-rosen-a-top-ranked-law-firm-encourages-brainstorm-cell-therapeutics-inc-investors-with-losses-in-excess-of-500k-to-secure-counsel-before-important-january-2-deadline/embed/#?secret=gVVUvKVdQl" width="600" height="338" title="“BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI” — Jordan News Gazette" data-secret="gVVUvKVdQl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities […]https://ci5.googleusercontent.com/proxy/jAc44G3_w6b7BF8DYvga8PVx5Tueo75VQqHWqDzU-b2BFNQF-kuvYU27g4W4pfePKKG3jLEzQUC7rgeisdjIdVVXN8cvX07iDs3b_HLntF7VpIbdhrLBImrRVC32dGOW8wlYg2ooOgvWrUEuV38oItnTTWhgyYY_c1eZMwVYnLcJhYHLDp6A31KXNse1HTwkyQ=s0-d-e1-ft#https://ml.globenewswire.com/media/NjI2M2EwZjYtNjEzNy00YWExLWFiZGItYWZiMzdhYjA4MDcyLTEwMzE5ODM=/tiny/The-Rosen-Law-Firm-PA.png